Imagenebio (IMA) Trading Update – 23 October 2026
Current Trading Session:
Imagenebio shares closed 1.09 % lower at 05:40 AM Central Europe time on Friday, 23 October 2026.
Market price: USD 4.04 per share on major exchanges.
Market Metrics:
Shares outstanding: 11.4 million.
Market capitalization: USD 46.9 million.
Volume in the last 24 hours: USD 29 000 worth of shares traded.
200‑day simple moving average: USD 5.72.
52‑week high: USD 9.10 (29 October 2025).
52‑week low: USD 3.90 (9 October 2026).
Recent Performance:
Since the end of September, Imagenebio shares have fallen 15.77 %.
Related Stocks – 24‑Hour Performance
| Symbol | Ticker | 24‑Hour Change | Current Price | Market Cap | Notes |
|---|---|---|---|---|---|
| Amc Robotics | AMCI | -6.93 % | USD 1.94 | USD 55.2 M | |
| Pantages Capital Acquisition | PGAC | +0.37 % | USD 10.81 | USD 55.3 M | P/E ratio 57.3 |
| Xilio Therapeutics | XLO | -1.29 % | USD 8.03 | USD 56.2 M | |
| Talphera | TLPH | 0 % | USD 1.05 | USD 55.5 M | |
| Sirnaomics | 2257.HK | +1.49 % | HKD 3.80 | HKD 440 M |
Company Overview
Ikena Oncology, Inc. (ticker: IMA) is a biotechnology firm focused on developing novel cancer therapies that target key signaling pathways involved in tumor formation and metastasis. The company’s research pipeline and clinical development strategy aim to address unmet needs in oncology.
